HIV protease as an inhibitor target for the treatment of AIDS.
Darke
P L
PL
Department of Biological Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486.
Huff
J R
JR
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D003461:Crystallography; D006678:HIV / Q000187:drug effects / Q000201:enzymology; D016333:HIV Protease / Q000648:ultrastructure; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans
D017320:HIV Protease Inhibitors; D016333:HIV Protease